| Document |
Document Title |
|
WO/2022/206300A1 |
Provided is a composition capable of facilitating defecation, comprising: lactic acid bacteria fermented powder containing a lactic acid bacteria fermented substance, the lactic acid bacteria fermented substance being obtained by culturi...
|
|
WO/2022/211587A1 |
The present invention relates to a novel Sphingomonas paucimobilis strain. The present invention also relates to use of the Sphingomonas paucimobilis strain. Particularly, the present invention relates to a method or composition for skin...
|
|
WO/2022/210308A1 |
The present invention addresses the problem of improving the productivity of a cyclic lipopeptide such as Surfactin by microbial culture. The present invention provides: a cyclic lipopeptide-producing microbial strain that lacks a gene...
|
|
WO/2022/211562A1 |
The present invention relates to a novel recombinant microalgal strain having enhanced resistance to high concentrations of CO2 and low pH (acidic) conditions and, more particularly, to Chlamydomonas reinhardtii PMA4ΔCter-V4 and -V10, w...
|
|
WO/2022/211736A1 |
Disclosed herein is a lipase variant comprising a first substituent of a lipase sequence of SEQ ID No. 2, wherein a position of the first substituent in SEQ ID No. 2 is selected from the group consisting of position 251, position 204, po...
|
|
WO/2022/206232A1 |
A fermented apple cider containing Chinese privet and a preparation method therefor. The method comprises the following steps: coring apples, then beating and crushing the apples, adding a sulfurous acid solution while crushing, and filt...
|
|
WO/2022/209658A1 |
The present invention addresses the problem of providing a new enzyme that specifically hydrolyzes an α-1,2-glucoside bond, and a production method therefor. The above problem is solved by providing an α-1,2-glucosidase which has activ...
|
|
WO/2022/199460A1 |
Disclosed are an aspartate kinase gene expression regulatory sequence and the use thereof. By modifying positions 366-373 of a sequence represented by SEQ ID NO: 1, a polynucleotide formed by linking the sequence with a start codon GTG o...
|
|
WO/2022/198846A1 |
Provided are a microorganism for producing a pantoic acid, and a construction method therefor and an application thereof. The microorganism for producing the pantoic acid is obtained by knocking out a gene in Escherichia coli and introdu...
|
|
WO/2022/203117A1 |
The present invention relates to an oncolytic virus for treating brain tumors by using a Newcastle disease virus vector-based recombinant Newcastle disease virus (NDV) into which a phosphatase and tensin homolog (PTEN) gene is inserted, ...
|
|
WO/2022/198990A1 |
A method for increasing the yield of eicosapentaenoic acid in Schizochytrium sp., the method comprising: inoculating Schizochytrium sp. ATCC 20888 into a fermentation culture medium, fermenting same under an aerobic condition, changing t...
|
|
WO/2022/200851A1 |
Disclosed herein is an isolated strain of Lactobacillus delbrueckii subsp. lactis LDL557, which is deposited at Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH under an accession number DSM 33617. Also disclosed herein are a ...
|
|
WO/2022/199660A1 |
Disclosed are Lactobacillus rhamnosus having the accession number of CCTCC NO: M 2021185, a ferment lysate prepared thereby for regulating skin microecology, and a preparation method for the lysate ferment. The ferment lysate comprises t...
|
|
WO/2022/198278A1 |
The present invention provides a hydrogel buoyant bead comprising cross-linked carbonic anhydrase, wherein the (hydrated) bead has a density of less than 1.03 g/cm3 (at 20°C). In one embodiment, the bead is a glutaraldehyde crosslinked ...
|
|
WO/2022/201197A1 |
The present invention provides a mutant yeast strain that is capable of alcohol fermentation, preferably high gravity fermentation (HGF) or very high gravity fermentation (VHGF). Particularly, the mutant yeast strain is of Meyerozyma car...
|
|
WO/2022/203008A1 |
Disclosed is a method for identifying bacteria that cause sepsis, wherein the method includes: a step for performing PCR using a sample collected from a subject and a combination of sets of primers each specific to the full length or a p...
|
|
WO/2022/203302A1 |
The present invention relates to a novel strain of Lactobacillus fermentum having an excellent effect of preventing or ameliorating an oral disease and use thereof. More specifically, the present invention relates to a strain of Lactobac...
|
|
WO/2022/194189A1 |
Provided in the present invention is a Lactobacillus Bangia fusco-purpurea fermentation supernatant having an α-glucosidase inhibitory activity. The method for preparing the Lactobacillus Bangia fusco-purpurea fermentation supernatant c...
|
|
WO/2022/197241A1 |
The present invention relates to a Bacillus subtilis strain isolate DSM33646 which is capable of propagating and secreting mannolytic enzymes to hydrolyse at least three forms of mannan polymers upon contact with solvent- extracted palm ...
|
|
WO/2022/195075A1 |
The present invention relates to the identification of a novel isolated lactic acid bacterial species. More specifically, a novel Latilactobacillus species, Latilactobacillus fragifolii sp. nov., with the type strain AMBP162T is proposed...
|
|
WO/2022/193398A1 |
Provided are a trivalent dimethylarsinous acid induced human keratinocyte malignant transformation cell strain, and the use thereof, which belong to the technical field of model construction. An inorganic arsenic metabolite trivalent dim...
|
|
WO/2022/192956A1 |
The present disclosure relates to compositions and methods for inducing encystment of and/or stabilising ciliate cells. In particular, the present disclosure relates to polymers and polymeric solutions, including hydrocolloids, which may...
|
|
WO/2022/193163A1 |
Provided are streptococcus thermophilus for producing γ-aminobutyric acid and an application thereof. The streptococcus thermophilus for producing γ-aminobutyric acid is named Streptomyces thermophilus ST 36 and is preserved in the Ins...
|
|
WO/2022/197957A1 |
An integrated process and corresponding apparatus that produces a relatively clean, delignified cellulose product from lignocellulosic biomass. The method includes treating a portion of the delignified cellulose itself as a substrate to ...
|
|
WO/2022/190022A1 |
Ascomycetous filamentous fungi genetically modified to produce proteins having reduced or no N-glycans of mammalian proteins are provided, comprising deletion or disruption of stt3 and/or cwh8 genes.
|
|
WO/2022/188834A1 |
Disclosed in the present invention are a method for strengthening biogenic manganese oxidation by using a magnetic field, and an application thereof. Manganese-oxidizing bacteria are inoculated into a culture medium containing Mn2+, magn...
|
|
WO/2022/188378A1 |
Provided is a method for preparing a quality control sphere of freeze-dried Escherichia coli. The method comprises the following steps: preparing bacterial sludge containing Escherichia coli, preparing a freeze-drying protective agent, u...
|
|
WO/2022/188403A1 |
Provided are a strain of Enterobacter chengduensis for producing nicotinamide mononucleotide (NMN) and the use thereof. The Enterobacter chengduensis is prepared by means of collecting soil from near a sewer of a factory for producing NM...
|
|
WO/2022/188162A1 |
Provided are an endophytic fungus in Ginkgo biloba, i.e., Fusarium oxysporum DZHQ2, and an anti-bacterial and antitumor application thereof. The preservation number of the Fusarium oxysporum is CCTCC No. M 2021211. A crude extract of a f...
|
|
WO/2022/188783A1 |
Provided are a construction method and application of an F gene-replaced chimeric measles attenuated strain. Specifically, the present invention provides a chimeric measles virus attenuated strain, and the attenuated strain is a measles ...
|
|
WO/2022/188784A1 |
Provided are a construction method for an H-gene-replaced chimeric measles attenuated strain and an application thereof. The attenuated strain is a measles virus rMV/H(H1a) having an accession number of CCTCCNO: V202074. Further provided...
|
|
WO/2022/183762A1 |
Disclosed are an anti-phenacetin monoclonal antibody hybridoma cell strain AD, and a preparation method therefor and the use thereof, which relate to the technical field of food safety and immunological detection. The deposit name of the...
|
|
WO/2022/183541A1 |
Provided is a codon-optimized hyaluronidase gene, and the nucleotide sequence thereof is as shown in SEQ ID NO. 1. A recombinant Pichia pastoris engineering strain, which is constructed by means of using the codon-optimized hyaluronidase...
|
|
WO/2022/183531A1 |
A cross-species cleavable Xanthomonas phage and a composition, a kit and the use thereof. The Xanthomonas axonopodis phage is the Xanthomonas phage GJ19P1 with the accession number of CCTCC NO: M 2020805; the composition at least contain...
|
|
WO/2022/184525A1 |
The present invention relates to a species of genus Pseudomonas identified as Pseudomonas BR87641, termed Candidatus Pseudomonas pretiosorbens, having Accession Deposit Number DSM 33684.
|
|
WO/2022/184746A1 |
The present application relates to novel depolymerized exopolysaccharides derived from microalgae, the method for obtaining same from microalgae, and their use for increasing the production of collagen and/or hyaluronic acid, in order to...
|
|
WO/2022/183593A1 |
Provided are a porcine alveolar macrophage healthy cell line, and a construction method and an application. The porcine alveolar macrophage healthy cell line has an accession number of CGMCC No: 21498. In the porcine alveolar macrophage ...
|
|
WO/2022/178578A1 |
The present invention relates to bacteria conferring bioprotection and/or biofertilizer properties to plants into which they are inoculated. More particularly, the present invention relates to endophyte strains of Paenibacillus sp., plan...
|
|
WO/2022/179073A1 |
Provided are an Aneurinibacillus sp. and the use thereof in the decolorization of dye wastewater. The Aneurinibacillus sp. is characterized in that: the Aneurinibacillus sp. is named Aneurinibacillus sp. YR-2, and was deposited in the Ch...
|
|
WO/2022/180534A1 |
The present invention relates to a vaccine composition comprising a host cell belonging to the genus Leishmania, wherein the host cell comprises a polynucleotide coding for at least one protein of a virus belonging to the family Coronavi...
|
|
WO/2022/179591A1 |
The present invention relates to the field of bioengineering, and specifically to genetically engineered bacillus subtilis for efficient exogenous protein expression and high-density culture. Genetic modification is performed on histidin...
|
|
WO/2022/178982A1 |
Provided are a bacterial colony formation method for sensitive and rapid culture of Helicobacter pylori and an effect evaluation method for same. The bacterial colony formation method comprises primary isolation, cryopreservation and rec...
|
|
WO/2022/174597A1 |
Provided are a genetically engineered bacterium for producing L-sarcosine, a construction method therefor and the use thereof. The genetically engineered bacterium takes escherichia coli as a host, and is obtained by means of integrating...
|
|
WO/2022/175600A1 |
A virucidal composition, a method of its manufacturing, related uses and end-user products are hereby provided. The composition comprises a mixture of biologically active substances obtainable from selected fungal strains of Ganoderma lu...
|
|
WO/2022/177569A1 |
The present disclosure describes the engineering of microbial cells for fermentative production of 3,4-dihydroxybenzoic acid and provides novel engineered microbial cells and cultures, as well as related 3,4-dihydroxybenzoic acid product...
|
|
WO/2022/175958A1 |
The present invention is in the field of biocontrol of plant insect and/or mite pests. Particularly, the present invention discloses bacterial strains effective in inhibiting the development of or in killing insects and/or mites, and/or ...
|
|
WO/2022/178432A1 |
Certain embodiments of the disclosure are related to compositions and methods for producing proteins of interest in pigment deficient Bacillus cells. Certain other embodiments are related to compositions and methods for obtaining pigment...
|
|
WO/2022/174663A1 |
A system and a method for instantly detecting nucleic acid of a pathogen. The system comprises a lysis buffer, which is used for inactivating and lysing a sample to be detected, so as to release RNA; an RT pre-mixed solution, which is us...
|
|
WO/2022/170394A1 |
The present invention provides recombinant strains of M. bovis BCG comprising a heterologous nucleic acid encoding a fusion protein, wherein the fusion protein comprises or consists of: a) a polypeptide that is at least about 80% identic...
|
|
WO/2022/172269A1 |
A method for improving a plant trait, comprising steps of: a. obtaining a plant; and b. inoculating said plant with at least one bacterium having at least one of sequences SEQ ID NO:l- SEQ ID NO: 17, as disclosed in the sequence listing ...
|
